Abstract:Bone cancer pain (BCP) is a severe complication of advanced bone cancer. Although cannabinoid receptor 2 (CB2) agonists may have an analgesic effect, the underlying mechanism remains unclear. CB2 serves a protective role in various pathological states through the activation of autophagy. Therefore, the present study aimed to determine whether the analgesic effects of the selective CB2 agonist JWH015 was mediated by the activation of autophagy in BCP. BCP was induced by the intra-femur implantation of NCTC2472 fibrosarcoma cells in C3H/HeN mice. The pain behaviors were assessed on the following postoperative days. The selective CB2 agonist JWH015 (1 and 2 mu g) was intrathecally administered on day 14 following implantation. AM630 (1 mu g), a CB2 antagonist, was injected 30 min before JWH015 administration. Lipopolysaccharide (LPS; 100 nM)-stimulated primary neurons were treated with JWH015 (1 mu M) and AM630 (1 mu M) to further verify the mechanism by which CB2 affects autophagy. The results demonstrated that autophagy flux was impaired in spinal neurons during BCP, as indicated by the increased ratio of microtubule-associated protein 1 light chain 3 beta (LC3B)-II/LC3B-I and increased expression of p62. Intrathecal administration of JWH015 attenuated BCP, which was accompanied by the amelioration of impaired autophagy flux (decreased LC3B-II/LC3B-I ratio and decreased p62expression). In addition, the activation of glia cells and upregulation of the glia-derived inflammatory mediators, interleukin (IL)-1 beta and IL-6 were suppressed by JWH015. In LPS-stimulated primary neurons, IL-1 beta and IL-6 were increased, and autophagy flux was impaired; whereas treatment with JWH015 decreased the expression of IL-1 beta and IL-6, LC3B-II/LC3B-I ratio and expression of p62. These effects were by pretreatment with the CB2-selective antagonist AM630. The results of the present study suggested that the impairment of autophagy flux was induced by glia-derived inflammatory mediators in spinal neurons. Intrathecal administration of the selective CB2 agonist JWH015 ameliorated autophagy flux through the downregulation of IL-1 beta and IL-6 and attenuated BCP.

<scp>USP48</scp> alleviates bone cancer pain and regulates <scp>MrgC</scp> stabilization in spinal cord neurons of male mice

USP48 alleviates bone cancer pain and regulates MrgC stabilization in spinal cord neurons of male mice.

Role of Spinal Neuronal Mas-related Gene Receptor C in Maintenance of Bone Cancer Pain in Mice

Mas-Related Gene (mrg) C Activation Attenuates Bone Cancer Pain Via Modulating Gi and NR2B

Activation of Spinal Mrgc-Gi-Nr2b-Nnos Signaling Pathway by Mas Oncogene-Related Gene C Receptor Agonist Bovine Adrenal Medulla 8-22 Attenuates Bone Cancer Pain in Mice

Inhibition of Connexin 43 and Phosphorylated NR2B in Spinal Astrocytes Attenuates Bone Cancer Pain in Mice.

Relationship Between Spinal Neuronal Microrna 212 and Phosphorylation of CREB in a Mouse Model of Bone Cancer Pain

MiR-135-5p Alleviates Bone Cancer Pain by Regulating Astrocyte-Mediated Neuroinflammation in Spinal Cord through JAK2/STAT3 Signaling Pathway

SIRT1 Activation Attenuates Bone Cancer Pain by Inhibiting Mglur1/5

Mas-Related G-Protein-Coupled Receptor C Agonist Bovine Adrenal Medulla 8-22 Attenuates Bone Cancer Pain in Mice

miR-155-5p in the spinal cord regulates hypersensitivity in a rat model of bone cancer pain

Role of Spinal Neuronal CREB-regulated Transcription Coactivator 1 in Maintenance of Bone Cancer Pain in Mice

Cannabinoid Receptor 2‑selective Agonist JWH015 Attenuates Bone Cancer Pain Through the Amelioration of Impaired Autophagy Flux Induced by Inflammatory Mediators in the Spinal Cord

Role of Gliocyte in Spinal Cord in Development of Bone Cancer Pain in Mice

Role of IL-1β and TNFα in the Spinal Cord in a Murine Model of Bone Cancer Pain Reduced by Activation of Glial Cells

Downregulated CAV-1 in Mouse Spinal Cord May Alleviate Bone Cancer Pain by Inhibiting the ERK/CREB Pathway.

Intrathecal Administration of SRT1720 Relieves Bone Cancer Pain by Inhibiting the CREB/CRTC1 Signalling Pathway

Spinal sirtuin 2 attenuates bone cancer pain by deacetylating FoxO3a

Relief of mechanical allodynia in rat model of bone cancer by intrathecal MCP-1 neutralizing antibody

Pain Behavior and the Expression of Phosphorylated Camp Response Element Binding Protein and Brain-Derived Neurotrophic Factor in Dorsal Horn of Spinal Cord in a Mouse Model of Bone Cancer Pain

Spinal Cannabinoid Receptor 2 Activation Reduces Hypersensitivity Associated with Bone Cancer Pain and Improves the Integrity of the Blood–spinal Cord Barrier